Pricing Disclaimer: Prices, offers, and program terms mentioned were observed on the company website on December 19, 2025, but are subject to change without notice
Mounjaro, the brand name tirzepatide medication that is FDA-approved for type 2 diabetes is not available through Ro
Insurance and cost considerations for medication switches Brand-name pricing (as of April 2026): Wegovy: $1,349 per month (list price) Zepbound: $1,059 per month (list price) Both manufacturers offer savings cards that reduce out-of-pocket cost to $25-$550 per month depending on insurance
Novo Nordisk), have both demonstrated around 20% weight loss after 72 weeks in previous clinical trials (SURMOUNT-1
Adults who have a BMI index of 30 kg/m^2 or higher (obesity) or 27 kg/m^2 or greater (overweight) with at least one weight-related health problem (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia) may benefit from GLP-1 injections combined with physical activity and a reduced calorie diet [11]
These were more frequent and dose dependent with monlunabant compared with placebo